CFDE Data Portal | Search FGFR4

	Label	Description
	FGFR4 Gene (Entity type)	ENSG00000160867 - fibroblast growth factor receptor 4
	FGFR4 associations Collection (Entity type)	Associations for FGFR4_associations
	FGFR4 Down Gene Set (Entity type)	A Gene Set from LINCS
	FGFR4 Up Gene Set (Entity type)	A Gene Set from LINCS
	FGFR4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NR1H3 Gene (Entity type)	ENSG00000025434 - nuclear receptor subfamily 1 group H member 3
	CAD Gene (Entity type)	ENSG00000084774 - carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
	SAR1A Gene (Entity type)	ENSG00000079332 - secretion associated Ras related GTPase 1A
	GSE114883 romidepsin T cell 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS

FGFR4

ENSG00000160867 - fibroblast growth factor receptor 4

FGFR4 associations

Associations for FGFR4_associations

FGFR4 Down

A Gene Set from LINCS

FGFR4 Up

A Gene Set from LINCS

FGFR4 associations.tsv

A file from IDG as part of the Harmonizome project

NR1H3

ENSG00000025434 - nuclear receptor subfamily 1 group H member 3

CAD

ENSG00000084774 - carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

SAR1A

ENSG00000079332 - secretion associated Ras related GTPase 1A

GSE114883 romidepsin T cell 1 v 2 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.